Literature DB >> 16550709

[The iron letter--an update on the treatment of iron deficiency anemia].

R M Schaefer1, R Huch, A Krafft.   

Abstract

Iron deficiency is a frequent complication in chronically ill patients and in pregnant women. Iron status can now be characterised precisely and relatively easily by determining serum ferritin, transferritin saturation and if necessary hypochromic erythrocytes and the haemoglobin content of erythrocytes (CHr). Oral iron replacement is usually restricted by limited absorption and low tolerability. Intravenous iron therapy is possible in such cases and can be combined with rHuEPO (e.g. EPREX/Epoetin alfa) in severe cases. Iron saccharate Switzerland and this permits high dose iron replacement without any danger of anaphylaxis or acute iron toxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16550709     DOI: 10.1024/0369-8394.95.10.357

Source DB:  PubMed          Journal:  Praxis (Bern 1994)        ISSN: 1661-8157


  4 in total

1.  Safety, therapeutic effectiveness, and cost of parenteral iron therapy.

Authors:  Suheyl Asma; Can Boga; Hakan Ozdogu
Journal:  Int J Hematol       Date:  2009-06-03       Impact factor: 2.490

2.  Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data.

Authors:  Elisabeth Brock; Peter Braunhofer; Josef Troxler; Heinz Schneider
Journal:  Eur J Health Econ       Date:  2013-10-01

3.  Mild anemia and pregnancy outcome in a Swiss collective.

Authors:  Gabriela Bencaiova; Christian Breymann
Journal:  J Pregnancy       Date:  2014-11-13

4.  Medication adherence to oral iron therapy in patients with iron deficiency anemia.

Authors:  Cigdem Gereklioglu; Suheyl Asma; Asli Korur; Ferit Erdogan; Altug Kut
Journal:  Pak J Med Sci       Date:  2016 May-Jun       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.